Literature DB >> 9587961

Species differences in stereoselective hydrolase activity in intestinal mucosa.

Y Yoshigae1, T Imai, A Horita, H Matsukane, M Otagiri.   

Abstract

PURPOSE: The aim of this study is to investigate species differences in the stereoselective hydrolysis for propranolol ester prodrugs in mammalian intestinal mucosa and Caco-2 cells.
METHODS: Hydrolase activities for propranolol prodrugs and p-nitrophenylacetate in man (age: 51-71 years), the beagle dog (age: 4 years) and Wistar rat (age: 8 weeks) intestinal mucosa, and also in Caco-2 cells (passage between 60-70) were estimated by determining the rate of production of proparanolol and p-nitrophenol, respectively.
RESULTS: The hydrolase activities for both propranolol prodrugs and p-nitrophenylacetate were in the order of man > rat >> Caco-2 cells > dog for intestinal microsomes, and rat > Caco-2 cells = man > dog for intestinal cytosol. Dog microsomes showed stereoselective hydrolysis for propranolol prodrugs, but not those from human or rat. Interestingly, both subcellular fractions of Caco-2 cells showed remarkable R-enantioselectivity except acetyl propranolol. Enzyme kinetic experiments for each enantiomer of butyryl propranolol in microsomes revealed that dog possesses both low and high affinity hydrolases. Both Km and Vmax values in rat were largest among examined microsomes, while Vmax/Km was largest in man. Finally, it was shown that the carboxylesterases might contribute to the hydrolysis of propranolol prodrug in all species by inhibition experiments.
CONCLUSIONS: The hydrolase activities for propranolol prodrugs and p-nitrophenylacetate in intestinal mucosa showed great species differences and those in human intestine were closer to those of rat intestine than dog intestine or Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9587961     DOI: 10.1023/a:1011946314416

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Esterase activity toward the diastereomers of cefuroxime axetil in the rat and dog.

Authors:  G L Mosher; J McBee; D B Shaw
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

2.  Kinetic analysis of the drug permeation process across the intestinal epithelium.

Authors:  S Yamashita; M Yoshida; Y Taki; T Sakane; T Nadai
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

3.  Stereoselective hydrolysis of xenobiotic esters by different cell lines from rat liver and hepatoma and its application to chiral prodrugs for designated growth suppression of cancer cells.

Authors:  Y Kageyama; Y Yamazaki; A S Afify; Y Ogawa; T Okada; H Okuno
Journal:  Chirality       Date:  1995       Impact factor: 2.437

4.  Hydrolysis of ester-type drugs by the purified esterase from human intestinal mucosa.

Authors:  M Inoue; M Morikawa; M Tsuboi; T Yamada; M Sugiura
Journal:  Jpn J Pharmacol       Date:  1979-02

5.  Gastrointestinal and hepatic first-pass metabolism of aspirin in rats.

Authors:  K Iwamoto; M Takei; J Watanabe
Journal:  J Pharm Pharmacol       Date:  1982-03       Impact factor: 3.765

6.  Enantioselectivity of microsomal and cytosolic esterases in rat intestinal mucosa.

Authors:  S K Yang; Y Y Hsieh; W C Chang; J D Huang
Journal:  Drug Metab Dispos       Date:  1992 Sep-Oct       Impact factor: 3.922

7.  Different expression of esterase variants in rat hepatic and hepatoma-derived cell lines detected by electrophoresis.

Authors:  A S Afify; Y Yamazaki; Y Kageyama; S Yusa; Y Ogawa; T Okada; H Okuno
Journal:  Z Naturforsch C J Biosci       Date:  1995 Sep-Oct

8.  Plasma propranolol levels in beagle dogs after administration of propranolol hemisuccinate ester.

Authors:  Y Garceau; I Davis; J Hasegawa
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

9.  Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver.

Authors:  I A de Lannoy; F Barker; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

10.  Phase I and II biotransformations in living CaCo 2 cells cultivated under serum-free conditions. Selective apical excretion of reaction products.

Authors:  T Sergent-Engelen; V Delistrie; Y J Schneider
Journal:  Biochem Pharmacol       Date:  1993-10-19       Impact factor: 5.858

View more
  1 in total

1.  Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.

Authors:  J Van Gelder; P Annaert; L Naesens; E De Clercq; G Van den Mooter; R Kinget; P Augustijns
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.